BE709011A - - Google Patents

Info

Publication number
BE709011A
BE709011A BE709011DA BE709011A BE 709011 A BE709011 A BE 709011A BE 709011D A BE709011D A BE 709011DA BE 709011 A BE709011 A BE 709011A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE709011A publication Critical patent/BE709011A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04Saturated ethers
    • C07C43/12Saturated ethers containing halogen
    • C07C43/123Saturated ethers containing halogen both carbon chains are substituted by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE709011D 1967-06-26 1968-01-05 BE709011A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR111950A FR1535615A (fr) 1967-06-26 1967-06-26 Procédé pour l'obtention de tétrahydro-1, 4-oxazines substituées en 2, 4 et en 2, 2, 4

Publications (1)

Publication Number Publication Date
BE709011A true BE709011A (en:Method) 1968-07-05

Family

ID=8633844

Family Applications (1)

Application Number Title Priority Date Filing Date
BE709011D BE709011A (en:Method) 1967-06-26 1968-01-05

Country Status (6)

Country Link
BE (1) BE709011A (en:Method)
CH (1) CH487919A (en:Method)
DE (1) DE1643857A1 (en:Method)
FR (1) FR1535615A (en:Method)
GB (1) GB1184023A (en:Method)
NL (1) NL147728B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657476A1 (de) * 1976-12-18 1978-06-22 Basf Ag Morpholinderivate
FR2517305B1 (fr) * 1981-12-01 1985-10-25 Lafon Labor Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
FR2553412B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
EP0140359B1 (en) * 1983-11-02 1989-01-25 Beecham Group Plc Morpholine derivatives
CA2071897A1 (en) * 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
JPH07503461A (ja) * 1992-01-28 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー カルシウムチャンネル拮抗薬としての化合物
EP0714292A4 (en) * 1993-06-23 1996-10-09 Cambridge Neuroscience Inc SIGMA RECEPTOR LIGANDS AND THEIR USE
AU2001290873B2 (en) 2000-09-11 2006-07-27 Sepracor Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
ATE507212T1 (de) 2005-01-18 2011-05-15 Hoffmann La Roche Morpholine als 5ht2c-agonisten

Also Published As

Publication number Publication date
DE1643857A1 (de) 1971-04-15
NL6801287A (en:Method) 1968-12-27
FR1535615A (fr) 1968-08-09
CH487919A (fr) 1970-03-31
NL147728B (nl) 1975-11-17
GB1184023A (en) 1970-03-11

Similar Documents

Publication Publication Date Title
AU425114B2 (en:Method)
AT298283B (en:Method)
AU342066A (en:Method)
AU2256867A (en:Method)
AU3189468A (en:Method)
AU3151267A (en:Method)
AU2977667A (en:Method)
AU2528767A (en:Method)
AU610966A (en:Method)
AU1273466A (en:Method)
AU2116667A (en:Method)
AU1677166A (en:Method)
AU34866A (en:Method)
AU2406369A (en:Method)
AU23366A (en:Method)
BE711453A (en:Method)
BE711533A (en:Method)
BE710483A (en:Method)
BE711541A (en:Method)
AU1868267A (en:Method)
BE710416A (en:Method)
AU1763766A (en:Method)
BE710324A (en:Method)
BE711723A (en:Method)
AU1614766A (en:Method)